Vivos Therapeutics, Inc. (VVOS) Earnings Report - Discounting Cash Flows
VVOS
Vivos Therapeutics, Inc.
VVOS (NASDAQ)
Period Ending: 2026
03-30
2025
11-19
2025
08-19
2025
05-15
2025
03-31
2024
11-14
2024
08-14
2024
05-14
2024
03-28
2023
11-14
2023
08-16
2023
06-08
2023
03-30
2022
12-20
2022
11-25
2022
08-23
2022
05-16
2021
11-15
2021
08-12
2021
05-17
2021
03-25
2020
12-14
2020
06-29
2020
03-31
2019
12-30
2019
09-29
2019
06-29
2019
03-30
Actual EPS - -0.49 -0.55 -0.45 -0.28 -0.40 -0.60 -1.63 -3.05 -1.75 -3.75 -5.00 -5.00 -8.25 -4.95 -8.27 -6.50 -6.50 -4.75 -4.75 -12.00 -3.63 -2.83 -5.17 -5.28 -6.24 -5.65 -5.65
Estimated EPS -0.46 -0.53 -0.27 -0.44 -0.43 -0.70 -1.05 -1.17 -1.90 -3.12 -3.75 -4.25 -5.50 -0.28 - - -7.25 -4.00 -4.00 -4.25 -5.25 - - - - - - -
Actual Revenue - 6.78 3.82 3.02 3.7 3.86 4.05 3.42 3.25 3.3 3.4 3.86 3.95 4.25 3.46 4.18 4.39 4.55 4.5 3.45 3.31 3.29 3.27 3.2 3.06 3.32 2.51 2.51
Estimated Revenue - 7.2 3.65 3.67 3.89 3.89 3.6 3.41 3.41 4.5 4.14 4.15 4.25 3.72 - 3.81 4.44 4.5 4.5 - - - - - - - - -
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program